Jan 2022 Unpredictability of Counterfeit Drugs
Novel Psychoactive Substances (NPS) are developed to bypass controlled drug legislation and evade detection by traditional drug testing methods. In...
In Practice: Clinical Insights
Aug 2021 Cases of Unusual Buprenorphine Concentrations in Urine Drug Tests: What Does This Mean and Clinical Implications?
Buprenorphine is a semisynthetic opioid with partial agonist activity at the mu-opioid receptor, an effective treatment option for opioid use...
Jun 2021 Finding Fentanyl
Synthetic opioids, including fentanyl, buprenorphine, meperidine, methadone and others,1 comprise a class of drugs manufactured in laboratories designed to have...
May 2021 Interpretation of Buprenorphine and Naloxone Results: Considerations for Dosage Form and Specimen Type
Buprenorphine prescribing is extremely common across multiple clinical specialties, primarily opioid use disorder (OUD) and pain management...
Dec 2020 An Overview of Dextromethorphan/Levorphanol Results
Accurate interpretation of dextromethorphan/levorphanol results should take into account the patient’s prescription and over-the-counter (OTC) drug regimen and the specimen...
Sep 2020 Emerging Data on Novel Psychoactive Substances and Clinical Effects
Emerging Data on Novel Psychoactive Substances and Clinical Effects Aegis launched an extensive and industry-leading testing menu of Novel Psychoactive Substances...
